Tracking Epidemiological Characteristics and Risk Factors of Multi-Drug Resistant Bacteria in Intensive Care Units

References

• Chacko B, Thomas K, David T, Paul H, Jeyaseelan L, Peter JV. Attributable cost of a nosocomial infection in the intensive care unit: a prospective cohort study. World J Crit Care Med. 2017;6(1):79–84. doi:10.5492/wjccm.v6.i1.79
   PubMedGoogle Scholar
• Bergmann JN, Killen-Cade RR, Parish LA, Albrecht MT, Wolfe DN. Partnering on Vaccines to Counter Multi-Drug Resistant Threats: Workshop Proceedings, Biomedical Advanced Research and Development Authority. Taylor & Francis; 2022.
   Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318.
   PubMed Web of Science ®Google Scholar
• Bloom G, Merrett GB, Wilkinson A, Lin V, Paulin S. Antimicrobial resistance and universal health coverage. BMJ Glob Health. 2017;2(4):e000518.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021; 2021.
   Google Scholar
• Han Y, Zhang J, Zhang HZ, Zhang XY, Wang YM. Multidrug-resistant organisms in intensive care units and logistic analysis of risk factors. World J Clin Cases. 2022;10(6):1795–1805.
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–s34.
   PubMed Web of Science ®Google Scholar
• Hanberger H, Arman D, Gill H, et al. Surveillance of microbial resistance in European intensive care units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med. 2009;35(1):91–100.
   PubMed Web of Science ®Google Scholar
• Luna CM, Rodriguez-Noriega E, Bavestrello L, Guzmán-Blanco M. Gram-negative infections in adult intensive care units of latin america and the Caribbean. Crit Care Res Pract. 2014;2014:480463.
   PubMedGoogle Scholar
• Shi J, Sun T, Cui Y, et al. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis. 2020;20(1):597. doi:10.1186/s12879-020-05321-y
   PubMed Web of Science ®Google Scholar
• De Waele JJ, Boelens J, Leroux-Roels I. Multidrug-resistant bacteria in ICU: fact or myth. Curr Opin Anaesthesiol. 2020;33(2):156–161. doi:10.1097/ACO.0000000000000830
   PubMed Web of Science ®Google Scholar
• Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM trials group project. Intensive Care Med. 2019;45(12):1703–1717. doi:10.1007/s00134-019-05819-3
   PubMed Web of Science ®Google Scholar
• Masters BR. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Graefes Arch Clin Exp Ophthalmol. 2016;254(11):2285–2287. doi:10.1007/s00417-015-2950-1
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Gilbert DN. The Sanford guide to antimicrobial therapy 2011. Antimicrob Ther. 2011;2011:4–62.
   Google Scholar
• Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93. doi:10.1016/j.ajic.2007.10.006
   PubMed Web of Science ®Google Scholar
• Rawat D, Nair D. Extended-spectrum β-lactamases in Gram Negative Bacteria. J Glob Infect Dis. 2010;2(3):263–274. doi:10.4103/0974-777X.68531
   PubMedGoogle Scholar
• Laboratory C, Institute S. Performance Standards for Antimicrobial Susceptibility Testing. PA: Clinical Laboratory and Standards Institute Wayne; 2019.
   Google Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Wang L, Huang X, Zhou J, et al. Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model. Antimicrob Resist Infect Control. 2020;9(1):66. doi:10.1186/s13756-020-00726-5
   PubMed Web of Science ®Google Scholar
• Zaragoza R, Vidal-Cortés P, Aguilar G, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020;24(1):383. doi:10.1186/s13054-020-03091-2
   PubMed Web of Science ®Google Scholar
• Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT. Eur Respir J. 2017;50:3.
   Google Scholar
• Burillo A, Muñoz P, Bouza E. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019;32(6):626–637. doi:10.1097/QCO.0000000000000599
   PubMed Web of Science ®Google Scholar
• Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis. 2014;14:615. doi:10.1186/s12879-014-0615-z
   PubMed Web of Science ®Google Scholar
• Sonti R, Conroy ME, Welt EM, Hu Y, Luta G, Jamieson DB. Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population. Ther Adv Infect Dis. 2017;4(4):95–103. doi:10.1177/2049936117715403
   PubMedGoogle Scholar
• Cucci M, Wooten C, Fowler M, Mallat A, Hieb N, Mullen C. Incidence and risk factors associated with multi-drug-resistant pathogens in a critically ill trauma population: a retrospective cohort study. Surg Infect. 2020;21(1):15–22. doi:10.1089/sur.2019.031
   PubMed Web of Science ®Google Scholar
• Strich JR, Palmore TN. Preventing transmission of multidrug-resistant pathogens in the intensive care unit. Infect Dis Clin North Am. 2017;31(3):535–550. doi:10.1016/j.idc.2017.05.010
   PubMed Web of Science ®Google Scholar
• Piano S, Singh V, Caraceni P, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156(5):1368–80.e10.
   PubMed Web of Science ®Google Scholar
• Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49(8):1175–1184.
   PubMed Web of Science ®Google Scholar
• Mathers AJ, Cox HL, Kitchel B, et al. Molecular dissection of an outbreak of carbapenem-resistant Enterobacteriaceae reveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. mBio. 2011;2(6):e00204–11.
   PubMed Web of Science ®Google Scholar
• Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148.
   Web of Science ®Google Scholar
• Wang Z, Xia Z. What we can do? The risk factors for multi-drug resistant infection in pediatric intensive care unit (PICU): a case-control study. Ital J Pediatr. 2020;46(1):17.
   PubMed Web of Science ®Google Scholar
• Xu W, He L, Liu C, et al. The effect of infection control nurses on the occurrence of pseudomonas aeruginosa healthcare-acquired infection and multidrug-resistant strains in critically-ill children. PLoS One. 2015;10(12):e0143692.
   PubMed Web of Science ®Google Scholar
• Silva AC, Nogueira PJ, Paiva J-A. Determinants of antimicrobial resistance among the different European countries: more than human and animal antimicrobial consumption. Antibiotics. 2021;10(7):834.
   Google Scholar
• Tacconelli E, Pezzani MD. Public health burden of antimicrobial resistance in Europe. Lancet Infect Dis. 2019;19(1):4–6.
   PubMed Web of Science ®Google Scholar